Vyne Therapeutics Stock Price Prediction
| VYNE Stock | USD 3.23 0.26 8.75% |
Oversold Vs Overbought
37
Oversold | Overbought |
EPS Estimate Next Quarter (0.25) | EPS Estimate Current Year (0.60) | EPS Estimate Next Year (0.87) | Wall Street Target Price 5.58 | EPS Estimate Current Quarter (0.23) |
Using Vyne Therapeutics hype-based prediction, you can estimate the value of Vyne Therapeutics from the perspective of Vyne Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Vyne Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Vyne because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Vyne Therapeutics after-hype prediction price | USD 3.26 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Vyne |
Vyne Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Vyne Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vyne Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Vyne Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Vyne Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Vyne Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vyne Therapeutics' historical news coverage. Vyne Therapeutics' after-hype downside and upside margins for the prediction period are 0.16 and 8.27, respectively. We have considered Vyne Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Vyne Therapeutics is moderately volatile at this time. Analysis and calculation of next after-hype price of Vyne Therapeutics is based on 3 months time horizon.
Vyne Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Vyne Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vyne Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vyne Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.99 | 5.01 | 0.03 | 0.12 | 6 Events / Month | 3 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.23 | 3.26 | 0.93 |
|
Vyne Therapeutics Hype Timeline
Vyne Therapeutics is at this time traded for 3.23. The entity has historical hype elasticity of 0.03, and average elasticity to hype of competition of -0.12. Vyne is estimated to increase in value after the next headline, with the price projected to jump to 3.26 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.93%, whereas the daily expected return is at this time at 0.99%. The volatility of related hype on Vyne Therapeutics is about 4089.8%, with the expected price after the next announcement by competition of 3.11. The company reported the previous year's revenue of 424 K. Net Loss for the year was (28.45 M) with profit before overhead, payroll, taxes, and interest of 477 K. Given the investment horizon of 90 days the next estimated press release will be in about 6 days. Check out Vyne Therapeutics Basic Forecasting Models to cross-verify your projections.Vyne Therapeutics Related Hype Analysis
Having access to credible news sources related to Vyne Therapeutics' direct competition is more important than ever and may enhance your ability to predict Vyne Therapeutics' future price movements. Getting to know how Vyne Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vyne Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| FATE | Fate Therapeutics | (0.04) | 10 per month | 0.00 | (0.16) | 11.34 | (10.11) | 34.46 | |
| CRBU | Caribou Biosciences | (0.13) | 7 per month | 0.00 | (0.02) | 8.22 | (6.63) | 28.53 | |
| KPTI | Karyopharm Therapeutics | (0.04) | 9 per month | 0.00 | (0.03) | 8.97 | (5.56) | 26.95 | |
| HOOK | Hookipa Pharma | (0.28) | 6 per month | 0.00 | (0.32) | 6.85 | (6.67) | 22.36 |
Vyne Therapeutics Additional Predictive Modules
Most predictive techniques to examine Vyne price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vyne using various technical indicators. When you analyze Vyne charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Vyne Therapeutics Predictive Indicators
The successful prediction of Vyne Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vyne Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vyne Therapeutics based on analysis of Vyne Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vyne Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vyne Therapeutics's related companies. | 2020 | 2021 | 2023 | 2024 (projected) | Payables Turnover | 0.29 | 0.51 | 0.46 | 0.24 | Days Of Inventory On Hand | 1.9K | 794.87 | 914.1 | 1.5K |
Story Coverage note for Vyne Therapeutics
The number of cover stories for Vyne Therapeutics depends on current market conditions and Vyne Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vyne Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vyne Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Vyne Therapeutics Short Properties
Vyne Therapeutics' future price predictability will typically decrease when Vyne Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vyne Therapeutics often depends not only on the future outlook of the potential Vyne Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vyne Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.3 M | |
| Cash And Short Term Investments | 93.3 M |
Complementary Tools for Vyne Stock analysis
When running Vyne Therapeutics' price analysis, check to measure Vyne Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vyne Therapeutics is operating at the current time. Most of Vyne Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vyne Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vyne Therapeutics' price. Additionally, you may evaluate how the addition of Vyne Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |